Literature DB >> 15841444

Endocannabinoids and liver disease.

Wladimiro Jiménez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15841444     DOI： 10.1002/hep.20714

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.

Authors:  Shannon S Glaser; Paolo Onori; Candace Wise; Fuguan Yang; Marco Marzioni; Domenico Alvaro; Antonio Franchitto; Romina Mancinelli; Gianfranco Alpini; Md Kamruzzaman Munshi; Eugenio Gaudio
Journal:  Dig Liver Dis       Date:  2010-02-13       Impact factor: 4.088

3.  Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis.

Authors:  Hongyan Liu; Xiao Gao; Ruixian Duan; Qiao Yang; Yaowen Zhang; Yongwei Cheng; Yan Guo; Wangxian Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

Review 4.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.